Stocks
Longeveron Inc.LGVN
NASDAQHealthcareBiotechnology$1.60
Price as of · delayed, not real-time
A clinical-stage biotechnology company developing cellular therapies for aging-related conditions, with its lead candidate Lomecel-B in trials for hypoplastic left heart syndrome and Alzheimer's disease. Investors track the stock for its exposure to the regenerative medicine space and its frequent volatility around clinical data readouts.
52W Range: $1.31-$12.30
Congressional Interest in Longeveron Inc. (LGVN)
No congressional trades have been disclosed for Longeveron Inc. (LGVN) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading LGVN?
No congressional trades found for this stock.